rs115461448
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_153460.4(IL17RC):c.970G>A(p.Ala324Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0141 in 1,604,258 control chromosomes in the GnomAD database, including 205 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.012 ( 21 hom., cov: 33)
Exomes 𝑓: 0.014 ( 184 hom. )
Consequence
IL17RC
NM_153460.4 missense
NM_153460.4 missense
Scores
2
16
Clinical Significance
Conservation
PhyloP100: 3.71
Publications
10 publications found
Genes affected
IL17RC (HGNC:18358): (interleukin 17 receptor C) This gene encodes a single-pass type I membrane protein that shares similarity with the interleukin-17 receptor (IL-17RA). Unlike IL-17RA, which is predominantly expressed in hemopoietic cells, and binds with high affinity to only IL-17A, this protein is expressed in nonhemopoietic tissues, and binds both IL-17A and IL-17F with similar affinities. The proinflammatory cytokines, IL-17A and IL-17F, have been implicated in the progression of inflammatory and autoimmune diseases. Multiple alternatively spliced transcript variants encoding different isoforms have been detected for this gene, and it has been proposed that soluble, secreted proteins lacking transmembrane and intracellular domains may function as extracellular antagonists to cytokine signaling. [provided by RefSeq, Feb 2011]
IL17RC Gene-Disease associations (from GenCC):
- chronic mucocutaneous candidiasisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- candidiasis, familial, 9Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0069948733).
BP6
Variant 3-9928397-G-A is Benign according to our data. Variant chr3-9928397-G-A is described in ClinVar as Benign. ClinVar VariationId is 475918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0118 (1805/152378) while in subpopulation SAS AF = 0.0184 (89/4832). AF 95% confidence interval is 0.0153. There are 21 homozygotes in GnomAd4. There are 931 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 1805 Unknown,AD gene.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| IL17RC | ENST00000403601.8 | c.970G>A | p.Ala324Thr | missense_variant | Exon 11 of 19 | 1 | NM_153460.4 | ENSP00000384969.3 | ||
| ENSG00000288550 | ENST00000683484.1 | n.886G>A | non_coding_transcript_exon_variant | Exon 10 of 24 | ENSP00000507040.1 |
Frequencies
GnomAD3 genomes AF: 0.0118 AC: 1799AN: 152260Hom.: 19 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
1799
AN:
152260
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0121 AC: 2921AN: 241526 AF XY: 0.0125 show subpopulations
GnomAD2 exomes
AF:
AC:
2921
AN:
241526
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0144 AC: 20891AN: 1451880Hom.: 184 Cov.: 41 AF XY: 0.0144 AC XY: 10428AN XY: 721828 show subpopulations
GnomAD4 exome
AF:
AC:
20891
AN:
1451880
Hom.:
Cov.:
41
AF XY:
AC XY:
10428
AN XY:
721828
show subpopulations
African (AFR)
AF:
AC:
132
AN:
33182
American (AMR)
AF:
AC:
464
AN:
43526
Ashkenazi Jewish (ASJ)
AF:
AC:
133
AN:
25876
East Asian (EAS)
AF:
AC:
63
AN:
39556
South Asian (SAS)
AF:
AC:
1440
AN:
85820
European-Finnish (FIN)
AF:
AC:
596
AN:
49854
Middle Eastern (MID)
AF:
AC:
38
AN:
5722
European-Non Finnish (NFE)
AF:
AC:
17243
AN:
1108324
Other (OTH)
AF:
AC:
782
AN:
60020
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
1357
2713
4070
5426
6783
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
658
1316
1974
2632
3290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0118 AC: 1805AN: 152378Hom.: 21 Cov.: 33 AF XY: 0.0125 AC XY: 931AN XY: 74516 show subpopulations
GnomAD4 genome
AF:
AC:
1805
AN:
152378
Hom.:
Cov.:
33
AF XY:
AC XY:
931
AN XY:
74516
show subpopulations
African (AFR)
AF:
AC:
191
AN:
41592
American (AMR)
AF:
AC:
253
AN:
15314
Ashkenazi Jewish (ASJ)
AF:
AC:
18
AN:
3472
East Asian (EAS)
AF:
AC:
13
AN:
5182
South Asian (SAS)
AF:
AC:
89
AN:
4832
European-Finnish (FIN)
AF:
AC:
127
AN:
10626
Middle Eastern (MID)
AF:
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1061
AN:
68038
Other (OTH)
AF:
AC:
38
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
93
186
279
372
465
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
55
ALSPAC
AF:
AC:
71
ESP6500AA
AF:
AC:
25
ESP6500EA
AF:
AC:
148
ExAC
AF:
AC:
1392
Asia WGS
AF:
AC:
47
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Candidiasis, familial, 9 Benign:1
Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Uncertain
DEOGEN2
Benign
.;.;.;T;.;.;.;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Benign
T;.;T;T;T;T;T;T;T
MetaRNN
Benign
T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;.;L;.;.;.;.;.
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Benign
.;N;N;N;.;N;N;N;N
REVEL
Benign
Sift
Benign
.;T;T;T;.;T;T;T;T
Sift4G
Benign
T;T;T;T;.;T;T;T;T
Polyphen
0.70, 1.0, 0.51
.;P;.;D;P;.;P;.;.
Vest4
MPC
0.44
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.